A group of five Minnesota lawmakers led by State Representative Andrew Smith (D) introduced House Bill 2906 today, marking another step toward expanding access to psychedelic-assisted therapies in the state.
The bill has been referred to the House Health Finance and Policy Committee for consideration. The measure was filed just a few days after a group of eight lawmakers introduced House Bill 2699, which would decriminalize the personal use, cultivation, and possession of psilocybin while establishing a Psychedelic Medicine Board.
House Bill 2906 would establish a state-sanctioned program for the research and therapeutic use of psychedelics, including psilocybin. The measure would direct the Department of Health to develop guidelines for administering psychedelics in controlled medical environments, focusing on treating conditions such as PTSD, depression, and substance use disorders. The bill also outlines funding for clinical research and establishes safety protocols for psychedelic therapy sessions.
The introduction of both bills reflects a growing interest in psychedelic policy reform. Advocates point to emerging research suggesting psychedelics can provide significant relief for mental health conditions when administered under professional supervision.
Currently Colorado and Oregon are the only states to legalize the therapeutic use of psilocybin, although several states have legislation pending or advancing in their legislatures.
